Pfizer begins early stage trial for oral COVID-19 drug

Mar 24, 2021

New York [US], March 24 : Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.

Germany to buy 1 million packages of Paxlovid pills against COVID-19

Dec 28, 2021

Berlin [Germany], December 28 (ANI/Sputnik): Germany will purchase a million packages of the Paxlovid antiviral drug against COVID-19 by Pfizer, and the first batches...

SEC to take decision on antiviral Covid pill today

Dec 27, 2021

New Delhi [India], December 27 : After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's...

Pfizer says its COVID-19 oral antiviral candidate reduces risk of hospitalisation by 89pc

Nov 05, 2021

New York [US], November 5 : American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89...

CSIR gets nod for Phase III trial of antiviral drug Umifenovir

Jun 19, 2020

New Delhi [India], June 19 : CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received permission for carrying out Phase III trial...

Zydus Cadila approaches DCGI to use hepatitis drug for COVID-19 clinical trial

May 05, 2020

New Delhi [India], May 5 : The country's top drug regulator, Drug Controller General of India (DCGI), has received an application from Zydus Cadila,...